SF

Syed Fazal

Active Director Director DIN 09251937
DIN 09251937 First appointment Jul 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2021
Shareholding value •••• Premium profile

About Syed Fazal

Data last updated:

Syed Fazal is a Director at Arcutis Pharmaceuticals Private Limited (since 2021). The company operates in Chemicals. Arcutis Pharmaceuticals Private Limited reported revenue of ₹59.4 Lakh (FY 2025).

DIN 09251937
Primary Designation Director
Industry Chemicals
First Appointment 23 Jul 2021
Oldest Company Age 5 yrs
Largest company Arcutis Pharmaceuticals Private Limited · ₹59.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Jul 20212021₹59.4 Lakh (FY 2025)Active

Board colleagues of Syed Fazal

NameDINCompanyDesignation
Mohammed Javeed09251936Arcutis Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arcutis Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Syed Fazal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Syed Fazal

Syed Fazal currently holds 1 directorship: Arcutis Pharmaceuticals Private Limited (Director, since 23 Jul 2021, revenue ₹59.4 Lakh (FY 2025)).

Syed Fazal was first appointed on 23 Jul 2021 as Director at Arcutis Pharmaceuticals Private Limited.

The current boards of Syed Fazal's companies include Mohammed Javeed (Arcutis Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available